Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Content :

Navigating the challenges of influenza vaccination

Life is a health journey and influenza is one of the top 5 major killers and leading causes of death in the world, causing 3 to 5 million cases of severe illness and up to 500,000 deaths worldwide every year. In the UK alone in the 2015-2016 flu season, over 2,100 people were admitted to hospital and over 200 people died. Vaccination is the cornerstone of protection for people and communities from the heavy burden of influenza and its fatal outcomes.

As a health journey partner, Sanofi is committed to fighting influenza. As the world’s largest supplier of influenza vaccines we produce approximately 40 percent of the vaccines distributed worldwide. Backed by 60 years of long-standing experience in influenza vaccine research, development and production, we are constantly working to save lives through new and innovative influenza vaccines.

 

©Win initiative/GettyImages

Sanofi, Empowering Life.


 

Updated: December 18, 2017